Bifidobacterium adolescentis postbiotic metabolites in doxorubicin-aged canine vascular endothelial cells
In a canine vascular endothelial cell model, metabolites from brown algae extract fermented by Bifidobacterium adolescentis LA20k9 reduced doxorubicin-induced aging markers and oxidative and inflammatory measures. This is a cell study, not evidence of human lifespan or health benefits. [1]
Automatic summary · not editorially reviewed
The key findings
The study used a canine vascular endothelial cell model in which aging was induced with doxorubicin, and results were compared with a doxorubicin-induced aging group. [1]
LA20k9 reduced aging-related β-galactosidase activity by 30% compared with the doxorubicin-induced aging group. [1]
The authors describe LA20k9 as a promising metabolite for a postbiotic strategy against vascular aging, based on cell-model findings. [1]
The source at a glance
- Study type / format
- In vitro cell study (abstract only)
- Population / context
- Canine vascular endothelial cells in culture, including a doxorubicin-induced aging group
- Summary based on
- Study abstract
- Original publication
- June 23, 2026
Canine endothelial cells and doxorubicin aging model
The abstract describes a canine vascular endothelial cell (CVEC) model. The stated aim was to assess anti-aging effects of metabolites derived from brown algae extract fermented by Bifidobacterium adolescentis Life Age 20-k9 (LA20k9) and to clarify cellular mechanisms. Aging was induced with doxorubicin, and results are reported relative to a doxorubicin-induced aging group. The abstract does not report sample sizes, replication or the full experimental protocol.
Supporting source [1]
Lower β-galactosidase and altered vascular markers
According to the abstract, LA20k9 promoted CVEC proliferation. It significantly reduced aging-related β-galactosidase activity, which decreased by 30% compared with the doxorubicin-induced aging group. The abstract also reports decreased levels of matrix metalloproteinases (MMPs), including MMP-1 and MMP-3, and increased vascular endothelial growth factor (VEGF) and basic fibroblast growth factor contents, described as anti-aging effects and improved vascular health. These are cell-level measurements; the abstract gives no data on animals or people.
Supporting source [1]
Oxidative stress, inflammation and proposed mechanisms
The abstract states that LA20k9 significantly reduced oxidative stress and inflammatory responses in CVECs, shown by decreased inflammatory factors and malondialdehyde and increased NAD, superoxide dismutase and glutathione content. Mechanistically, it reports activation of the cell cycle system, cAMP signaling and retinol metabolism while inhibiting cellular senescence, oxidative damage and inflammatory responses. The authors call LA20k9 a promising metabolite for a postbiotic strategy against vascular aging; this is a proposal from a cell model, not a demonstrated human benefit.
Supporting source [1]
How to interpret this
This explainer is based only on the abstract; the full text was not reviewed. The abstract reports a cell-culture model, not animals or humans, and gives no sample sizes, replication details or long-term outcomes. Findings on senescence markers, oxidative and inflammatory measures and signaling pathways do not establish human health or lifespan benefits.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Jin H, Bai H, Liu T, Wang H, Li Y, Wang Z. · europepmc.org · June 23, 2026